List of Tables
Table 1. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Molecular Diagnostic Test
Table 3. Key Players of POC Infectious Disease Diagnostics Test
Table 4. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Infectious Disease Diagnostics Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Infectious Disease Diagnostics Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Infectious Disease Diagnostics Testing Market Share by Region (2018-2023)
Table 8. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Infectious Disease Diagnostics Testing Market Share by Region (2024-2029)
Table 10. Infectious Disease Diagnostics Testing Market Trends
Table 11. Infectious Disease Diagnostics Testing Market Drivers
Table 12. Infectious Disease Diagnostics Testing Market Challenges
Table 13. Infectious Disease Diagnostics Testing Market Restraints
Table 14. Global Infectious Disease Diagnostics Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Infectious Disease Diagnostics Testing Revenue Share by Players (2018-2023)
Table 16. Global Top Infectious Disease Diagnostics Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2022)
Table 17. Global Infectious Disease Diagnostics Testing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Infectious Disease Diagnostics Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Infectious Disease Diagnostics Testing, Headquarters and Area Served
Table 20. Global Key Players of Infectious Disease Diagnostics Testing, Product and Application
Table 21. Global Key Players of Infectious Disease Diagnostics Testing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2024-2029)
Table 27. Global Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Infectious Disease Diagnostics Testing Revenue Share by Application (2018-2023)
Table 29. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Infectious Disease Diagnostics Testing Revenue Share by Application (2024-2029)
Table 31. North America Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Infectious Disease Diagnostics Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Infectious Disease Diagnostics Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Infectious Disease Diagnostics Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Infectious Disease Diagnostics Testing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Infectious Disease Diagnostics Testing Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size by Country (2024-2029) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Infectious Disease Diagnostics Testing Product
Table 66. Abbott Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 67. Abbott Recent Developments
Table 68. bioMérieux Company Details
Table 69. bioMérieux Business Overview
Table 70. bioMérieux Infectious Disease Diagnostics Testing Product
Table 71. bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 72. bioMérieux Recent Developments
Table 73. Diasorin Company Details
Table 74. Diasorin Business Overview
Table 75. Diasorin Infectious Disease Diagnostics Testing Product
Table 76. Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 77. Diasorin Recent Developments
Table 78. Roche Diagnostic Company Details
Table 79. Roche Diagnostic Business Overview
Table 80. Roche Diagnostic Infectious Disease Diagnostics Testing Product
Table 81. Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 82. Roche Diagnostic Recent Developments
Table 83. Beckman Coulter Company Details
Table 84. Beckman Coulter Business Overview
Table 85. Beckman Coulter Infectious Disease Diagnostics Testing Product
Table 86. Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 87. Beckman Coulter Recent Developments
Table 88. Becton, Dickinson and Company Company Details
Table 89. Becton, Dickinson and Company Business Overview
Table 90. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product
Table 91. Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 92. Becton, Dickinson and Company Recent Developments
Table 93. Bio-Rad Laboratories Company Details
Table 94. Bio-Rad Laboratories Business Overview
Table 95. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product
Table 96. Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 97. Bio-Rad Laboratories Recent Developments
Table 98. Cavidi Company Details
Table 99. Cavidi Business Overview
Table 100. Cavidi Infectious Disease Diagnostics Testing Product
Table 101. Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 102. Cavidi Recent Developments
Table 103. Cepheid Company Details
Table 104. Cepheid Business Overview
Table 105. Cepheid Infectious Disease Diagnostics Testing Product
Table 106. Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 107. Cepheid Recent Developments
Table 108. Corgenix Company Details
Table 109. Corgenix Business Overview
Table 110. Corgenix Infectious Disease Diagnostics Testing Product
Table 111. Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 112. Corgenix Recent Developments
Table 113. Diaxonhit Company Details
Table 114. Diaxonhit Business Overview
Table 115. Diaxonhit Infectious Disease Diagnostics Testing Product
Table 116. Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 117. Diaxonhit Recent Developments
Table 118. Eiken Chemical Company Details
Table 119. Eiken Chemical Business Overview
Table 120. Eiken Chemical Infectious Disease Diagnostics Testing Product
Table 121. Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 122. Eiken Chemical Recent Developments
Table 123. EMD Millipore Company Details
Table 124. EMD Millipore Business Overview
Table 125. EMD Millipore Infectious Disease Diagnostics Testing Product
Table 126. EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 127. EMD Millipore Recent Developments
Table 128. Epitope Diagnostic Company Details
Table 129. Epitope Diagnostic Business Overview
Table 130. Epitope Diagnostic Infectious Disease Diagnostics Testing Product
Table 131. Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 132. Epitope Diagnostic Recent Developments
Table 133. EUROIMMUN Company Details
Table 134. EUROIMMUN Business Overview
Table 135. EUROIMMUN Infectious Disease Diagnostics Testing Product
Table 136. EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 137. EUROIMMUN Recent Developments
Table 138. Gold Standard Diagnostics Company Details
Table 139. Gold Standard Diagnostics Business Overview
Table 140. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product
Table 141. Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 142. Gold Standard Diagnostics Recent Developments
Table 143. Hologic Company Details
Table 144. Hologic Business Overview
Table 145. Hologic Infectious Disease Diagnostics Testing Product
Table 146. Hologic Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 147. Hologic Recent Developments
Table 148. Immunetics Company Details
Table 149. Immunetics Business Overview
Table 150. Immunetics Infectious Disease Diagnostics Testing Product
Table 151. Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 152. Immunetics Recent Developments
Table 153. InBios International Company Details
Table 154. InBios International Business Overview
Table 155. InBios International Infectious Disease Diagnostics Testing Product
Table 156. InBios International Revenue in Infectious Disease Diagnostics Testing Business (2018-2023) & (US$ Million)
Table 157. InBios International Recent Developments
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Infectious Disease Diagnostics Testing Market Share by Type: 2022 VS 2029
Figure 3. Molecular Diagnostic Test Features
Figure 4. POC Infectious Disease Diagnostics Test Features
Figure 5. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Infectious Disease Diagnostics Testing Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Academics Research Case Studies
Figure 9. Others Case Studies
Figure 10. Infectious Disease Diagnostics Testing Report Years Considered
Figure 11. Global Infectious Disease Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Infectious Disease Diagnostics Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Infectious Disease Diagnostics Testing Market Share by Region: 2022 VS 2029
Figure 14. Global Infectious Disease Diagnostics Testing Market Share by Players in 2022
Figure 15. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Infectious Disease Diagnostics Testing Revenue in 2022
Figure 17. North America Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)
Figure 19. North America Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)
Figure 20. North America Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)
Figure 21. United States Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Infectious Disease Diagnostics Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)
Figure 25. Europe Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)
Figure 26. Europe Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)
Figure 27. Germany Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Infectious Disease Diagnostics Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)
Figure 35. China Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)
Figure 36. Asia Infectious Disease Diagnostics Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)
Figure 38. Asia Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)
Figure 39. Asia Infectious Disease Diagnostics Testing Market Share by Region (2018-2029)
Figure 40. Japan Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Infectious Disease Diagnostics Testing Market Share by Country (2018-2029)
Figure 50. Brazil Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Infectious Disease Diagnostics Testing Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 57. bioMérieux Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 58. Diasorin Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 59. Roche Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 60. Beckman Coulter Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 61. Becton, Dickinson and Company Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 63. Cavidi Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 64. Cepheid Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 65. Corgenix Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 66. Diaxonhit Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 67. Eiken Chemical Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 68. EMD Millipore Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 69. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 70. EUROIMMUN Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 71. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 72. Hologic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 73. Immunetics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 74. InBios International Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed